Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors

Biomaterials - Tập 33 - Trang 4741-4751 - 2012
Yongzhong Wang1,2, Junguo Hao1, Yajuan Li1, Zhiwen Zhang1, Xianyi Sha1, Limei Han1, Xiaoling Fang1
1Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 200032, China
2School of Life Sciences, Anhui University, Hefei 230039, China

Tài liệu tham khảo

Filipits, 2004, Mechanisms of cancer: multidrug resistance, Drug Discov Today Dis Mech, 1, 229, 10.1016/j.ddmec.2004.10.001 Krishna, 2001, Modulation of P-glycoprotein (PGP) mediated multidrug resistance (MDR) using chemosensitizers: recent advances in the design of selective MDR modulators, Curr Med Chem Anticancer Agents, 1, 163, 10.2174/1568011013354705 Zastre, 2004, Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-polycaprolactone amphiphilic diblock copolymers, Pharm Res, 21, 1489, 10.1023/B:PHAM.0000036925.45002.a2 Mamot, 2003, Liposome-based approaches to overcome anticancer drug resistance, Drug Resist Updat, 6, 271, 10.1016/S1368-7646(03)00082-7 Kabanov, 2002, Pluronic((R)) block copolymers for overcoming drug resistance in cancer, Adv Drug Deliv Rev, 54, 759, 10.1016/S0169-409X(02)00047-9 Alakhov, 1999, Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials, Colloids Surf B Biointerfaces, 16, 113, 10.1016/S0927-7765(99)00064-8 Lee, 2005, Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor, J Control Release, 103, 405, 10.1016/j.jconrel.2004.12.018 Wang, 2007, Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines, Int J Pharm, 337, 63, 10.1016/j.ijpharm.2006.12.033 Wang, 2008, Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles, Arch Pharm Res, 31, 530, 10.1007/s12272-001-1189-2 Kim, 2001, Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers, Biomaterials, 22, 1697, 10.1016/S0142-9612(00)00292-1 Zastre, 2002, Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers, Eur J Pharm Biopharm, 54, 299, 10.1016/S0939-6411(02)00119-4 Ha, 1999, Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (pluronic)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres - I. Preparation and characterization, J Control Release, 62, 381, 10.1016/S0168-3659(99)00167-4 Kim, 2000, Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres - II. Thermo-responsive drug release behaviors, J Control Release, 65, 345, 10.1016/S0168-3659(99)00207-2 Ge, 2002, Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon- caprolactone)-poly(ethylene oxide)-poly(epsilon- caprolactone) amphiphilic triblock copolymer micelles, J Pharm Sci, 91, 1463, 10.1002/jps.10143 Shin, 1998, Methoxy poly(ethylene glycol)/[epsilon]-caprolactone amphiphilic block copolymeric micelle containing indomethacin.: I. Preparation and characterization, J Control Release, 51, 1, 10.1016/S0168-3659(97)00164-8 Han, 2008, Establishment and biological characterization of paclitaxel-resistant cell line of human ovarian carcinoma, Fudan Univ J Med Sci, 35, 171 Miller, 1997, Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption, Bioconjug Chem, 8, 649, 10.1021/bc970118d Garewal, 1986, ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects, J Natl Cancer Inst, 77, 1039 Salvioli, 2000, Opposite role of changes in mitochondrial membrane potential in different apoptotic processes, FEBS Lett, 469, 186, 10.1016/S0014-5793(00)01266-7 Marchetti, 1996, Mitochondrial permeability transition is a central coordinating event of apoptosis, J Exp Med, 184, 1155, 10.1084/jem.184.3.1155 Simon, 2005, Low dose (-)deprenyl is cytoprotective: it maintains mitochondrial membrane potential and eliminates oxygen radicals, Life Sci, 78, 225, 10.1016/j.lfs.2005.04.078 de Laat, 1977, Microviscosity modulation during the cell cycle of neuroblastoma cells, Proc Natl Acad Sci U S A, 74, 4458, 10.1073/pnas.74.10.4458 Batrakova, 2001, Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization, J Pharmacol Exp Ther, 299, 483 Batrakova, 2003, Sensitization of cells overexpressing multidrug-resistant proteins by Pluronic P85, Pharm Res, 20, 1581, 10.1023/A:1026179132599 Kim, 2001, In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy, J Control Release, 72, 191, 10.1016/S0168-3659(01)00275-9 Yoo, 2004, Folate receptor targeted biodegradable polymeric doxorubicin micelles, J Control Release, 96, 273, 10.1016/j.jconrel.2004.02.003 Wang, 2003, Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway, World J Gastroenterol, 9, 1904, 10.3748/wjg.v9.i9.1904 Rapoport, 2003, Drug delivery in polymeric micelles: from in vitro to in vivo, J Control Release, 91, 85, 10.1016/S0168-3659(03)00218-9 Lee, 1994, Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen, Mol Pharmacol, 46, 627 Wang, 2008, Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor, Acta Pharmaceutica Sinica, 43, 640 Gao, 2005, Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound, J Control Release, 102, 203, 10.1016/j.jconrel.2004.09.021 Kabanov, 2002, Pluronic (R) block copolymers as novel polymer therapeutics for drug and gene delivery, J Control Release, 82, 189, 10.1016/S0168-3659(02)00009-3 Batrakova, 1999, Fundamental relationships between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells, Pharm Res, 16, 1373, 10.1023/A:1018942823676 Wang, 2008, Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with pluronic P105/poly(caprolactone) copolymers, Pharmazie, 63, 446 Kwon, 1996, Polymeric micelles as new drug carriers, Adv Drug Deliv Rev, 21, 107, 10.1016/S0169-409X(96)00401-2